A host–guest approach for determining drug–DNA interactions: an example using netropsin by Goodwin, Kristie D. et al.
A host–guest approach for determining drug–DNA
interactions: an example using netropsin
Kristie D. Goodwin, Eric C. Long
1 and Millie M. Georgiadis*
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine and
1Department of Chemistry and Chemical Biology, Purdue School of Science, Indiana University-Purdue
University Indianapolis (IUPUI), IN 46202, USA
Received June 1, 2005; Revised and Accepted July 1, 2005
ABSTRACT
Netropsin is a well-characterized DNA minor groove
binding compound that serves as a model for the
study of drug–DNA interactions. Our laboratory has
developed a novel host–guest approach to study
drug–DNA interactions in which the host, the N-
terminal fragment of Moloney murine leukemia virus
reverse transcriptase (MMLV RT) is co-crystallized
with a DNA oligonucleotide guest in the presence
and absence of drug. We have co-crystallized netrop-
sin with the RT fragment bound to the symmetric
16mer d(CTTAATTCGAATTAAG)2 and determined
the structure of the complex at 1.85 A ˚. In contrast to
previously reported netropsin–DNA structures, our
oligonucleotide contains two AATT sites that bind
netropsin with flanking 50 and 30 sequences that
are not symmetric. The asymmetric unit of the RT
fragment–DNA–netropsin crystals contains one pro-
tein molecule and one-half of the 16mer with one
netropsin molecule bound. The guanidinium moiety
of netropsin binds in a narrow part of the minor
groove, while the amidinium is bound in the widest
region within the site. We compare this structure to
other Class I netropsin–DNA structures and find that
the asymmetry of minor groove widths in the AATT
site contributes to the orientation of netropsin within
the groove while hydrogen bonding patterns vary in
the different structures.
INTRODUCTION
Our laboratory has developed a host–guest approach to crys-
tallize and analyze the structures of DNA sequences of interest
(1–5). In developing this system, one of our goals has been to
study DNA–drug interactions. The host–guest system differs
from other methods of DNA crystallization in that a DNA
oligonucleotide (guest) is co-crystallized with a protein (host),
the N-terminal fragment of the Moloney murine leukemia
virus reverse transcriptase (MMLV RT). Here, we present
the use of this system to study drug–DNA interactions. This
method has several advantages over DNA-only crystals in
which the DNA–DNA interactions govern lattice formation.
One of the primary advantages is that the crystal lattice is
comprised of protein–protein and protein–DNA interactions,
but does not contain DNA–DNA interactions (1–5). Thus,
there is an  10 A ˚-thick cylindrical shell parallel to the helical
axis that surrounds each DNA molecule and is available for
interactions with DNA-speciﬁc binding compounds. A second
advantage is that in contrast to DNA-only crystals, any DNA
sequence can be analyzed using our system as interactions
with the protein are limited to the 30-OH end of one strand
and minor groove base atoms and sugar atoms of the terminal
3 bp (1–5). The third major advantage is that once crystals
have been obtained, the structure can be phased by molecular
replacement using the RT fragment as the search model pro-
viding unbiased electron density for the DNA (1–5).
Herein, we chose to focus our initial efforts on the well-
studied drug netropsin in order to validate the host–guest
approach to studying DNA–drug interactions. The netropsin
study provides an opportunity to compare essential features of
the DNA–drug interface found in our crystal structure with
those previously reported but is also of interest in its own right.
Netropsin is a site-selective minor groove DNA binder with a
preference for binding AT sites (6). AT-rich sites have a dee-
per minor groove, as compared with GC sites that contain an
N2amine,anddisplayanarrowerminorgroove duetoahigher
propeller twist and a deeper electrostatic potential that accom-
modates the charged amidinium and guanidinium groups
on the termini of the netropsin molecule (7). Despite having
been studied extensively, fundamental questions still remain
regarding details of the netropsin–DNA interaction (e.g. fac-
tors responsible for drug–DNA orientation) that in a broad
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doi:10.1093/nar/gki717sense, continue to impact our general understanding of
drug–DNA interactions. Two classes of netropsin binding
have been described (8). Netropsins that exhibit Class I bind-
ing have a single orientation on the DNA and are positioned
such that each amide group is situated between consecutive
base pairs (8–13). These amide NH groups make bifurcated
hydrogen bonds to A or T bases on the opposite strands, and
the pyrrole rings rest against the C2 of A in one AT pair. Class
II netropsins display end-for-end disorder (14,15). This type of
binding eliminates the speciﬁcity of netropsin for AT sites
because the drug is shifted down the minor groove where
the pyrrole rings (instead of amide nitrogens as in Class I)
are between base pairs, and there are no bifurcated hydrogen
bonds.
The Class I structures of the netropsin–DNA complex
have included several sequences of DNA with various
AT-containing sites (8–13). In the majority of these structures,
netropsin is bound to an oligonucleotide containing the AATT
sequence. Although these oligonucleotides and their netropsin
binding sites are sequence-symmetric, netropsin was bound
to the DNA in onlyone orientation. In the absence of structural
differences within the AATT that might result in asymmetry,
netropsin could theoretically bind in two different orientations
leading to end-for-end disorder as is seen in the Class II struc-
tures of netropsin bound to DNA.
Using our host–guest approach, we have analyzed the
interaction of netropsin with a 16mer DNA oligonucleotide
containing two AATT sites in the context of the N-terminal
fragment of MMLV RT. Our system has allowed us to exam-
ine netropsin binding for the ﬁrst time in a non-sequence
symmetric environment and has revealed that the orienta-
tion of netropsin binding is correlated with placement of
the guanidinium end in the narrowest part of the minor groove,
corresponding to the 30 end of the AATT sequence within the
structure. Although the structure of the 16mer DNA oligonuc-
leotide in the absence of netropsin differs in detail from that
of the netropsin complex, the minor groove widths are virtu-
ally identical suggesting that the groove width is a structural
property of the AATT site. A comparative analysis of the
DNA structures and hydrogen bonding patterns with previ-
ously reported netropsin–DNA structures reveals that only
the minor groove width is correlated with the orientation of
the netropsin in all of these structures.
MATERIALS AND METHODS
Crystallization and data collection
The DNA oligonucleotide d(CTTAATTCGAATTAAG)2con-
taining two netropsin binding sites was synthesized by TriLink
BioTechnologies (San Diego, CA) and puriﬁed using standard
reverse-phase HPLC methods. Correct placement of the net-
ropsin binding site within the oligonucleotide was important
because the ﬁrst 3 bp of the oligonucleotide are involved in
interactions with the protein. Thus, the AATT site within the
oligonucleotide must be placed at the fourth base from the
terminus to allow space for the drug to interact with the DNA.
The puriﬁed oligonucleotide was resuspended in 10 mM
MgCl2 and 10 mM HEPES pH 7.0 and annealed prior to
crystallization studies by heating to 80 C followed by
slow cooling to room temperature. The RT fragment (residues
24–278) was puriﬁed as previously described by Ni-NTA
afﬁnity chromatography followed by S-Sepharose ion
exchange chromatography (5). The 6·His-tag was removed
by thrombin digestion and again subjected to S-Sepharose ion-
exchange chromatography. Typical yields are 5–10 mg/l
culture. Finally, the protein was concentrated to  2m Mi n
0.3 M NaCl/100 mM MES pH 6.0 for use in crystallization
experiments.
Protein–DNA crystals were grown by hanging drop vapor
diffusion crystallization at 20 C in 7% PEG 4000, 5 mM mag-
nesium acetate and 50 mM ADA pH 6.5 from a 1:2 ratio of
protein:DNA. The crystals were  60 · 160 · 200 m
3.T h e
protein:DNA crystals were then used to microseed drops
including a 1:2:8 ratio of protein:DNA:netropsin. Stock con-
centrations of the components were 2 mM RT fragment in
50 mM MES pH 6.0/0.3 M NaCl, 2.5 mM oligonucleotide in
10 mM HEPES pH 7.0/10 mM MgCl2 and 25 mM netropsin
in 100 mM HEPES pH 8.0. Final concentrations in the drop
were 0.38 mM RT, 0.75 mM DNA and 2.9 mM netropsin.
The protein–DNA crystals were stabilized in 20% ethylene
glycol, 9% PEG 4000, 5 mM magnesium acetate and
100 mM HEPES pH 8.0. Additional cryosoaks containing
0.5, 1 and 2.5 mM netropsin were performed for the drug
complex crystals. A 1.8 A ˚ data set for the protein–DNA crys-
tals was collected at beamline 19-BM of the Advanced
Photon Source (Argonne, IL), and a 1.85 A ˚ data set for the
netropsin-containing crystals was collected on an R-axis IV
++
detector mounted on a home source (Table 1). The presence
of the drug in the crystals seems to improve the diffraction
data; similarly sized crystals of the DNA:protein complex
in the absence of drug diffracted to  2.3 A ˚ using home source
X-rays.Data were integrated andprocessed with theHKL2000
package (16). Both crystals are orthorhombic, space group
P21212, with unit cell dimensions of a ¼ 54.57 A ˚,
Table 1. Summary of crystallographic and refinement data
Cell parameters RT:DNA RT:DNA:Net
Cell constants (A ˚) a ¼ 54.93 a ¼ 54.57
b ¼ 145.75 b ¼ 145.61
c ¼ 46.86 c ¼ 46.81
Space group P21212P 2 1212
Statistics
Maximum resolution 1.8 A ˚ 1.85 A ˚
Reflections (unique) 35445 32157
(total) 169451 142521
Completeness (%) 98.9 (97.6) 98.1 (99.7)
Rsym
a (%) 5.2 (32.3) 5.3 (44.5)
I/s 19.7 (4.4) 27.6 (2.8)
Refinement
Resolution range (A ˚) 50–1.8 50–1.85
Number of waters 237 288
Average B-factor (A ˚ 2)
Protein 29.2 26.2
DNA 56.5 39.6
Netropsin N/A 58.2
Water 31.9 32.1
Rvalue
b (%) 22.7 22.0
Rfree (%) 26.4 24.6
Data in parentheses are for highest resolution shell.
aRsym ¼ SSi|Ii-<I> |/S<I> where I is the integrated intensity of a reflection.
bRvalue ¼ ShklkFobs   kFcalc|/Shkl|Fobs|. 5% of all reflections were omitted
from refinement and Rfree is the same statistic calculated for these
reflections.
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and a ¼ 54.93 A ˚, b ¼ 145.75 A ˚, c ¼ 46.86 A ˚ without
the drug.
Structure determination and refinement
We performed molecular replacement with AMoRe (17) using
the reﬁned structural model of the protein fragment from a
previously analyzed crystal as the search model [PDB acces-
sion ID, 1N4L (4)]. This model was subjected to rigid-body,
positional and B-factor reﬁnement using the data collected
fromprotein–DNA crystals toobtainunbiased electrondensity
of the DNA. We generated an idealized B-form model of the
correct DNA sequence using Nucleic Acid Builder (18) with a
uniform rise of 3.38 A ˚ and twist of 36 . This model was then
adjusted to ﬁt the Fo–Fc and 2Fo–Fc electron density maps
using O (19) and reﬁned. Next, water molecules were added to
the structural model followed by further positional and indi-
vidual B-factor reﬁnement. The DNA model was assessed
using Fo–Fc maps and simulated annealing omit maps (20)
to correct errors in positioning of the backbone and base
atoms. We note that there is no model bias from the DNA
prior to the interpretation of the unbiased difference electron
density maps and adjustment of the initial DNA model, and
that signiﬁcant adjustments to the idealized DNA model were
required in order to ﬁt the difference electron density maps.
Ultimately, 237 water molecules were positioned around the
protein molecule in this structure. As in other structures that
we have determined in this crystal form (1–4), there are no
ordered water molecules associated with the DNA. Alternate
cycles of model building using O (19) and reﬁnement using
calculations in CNS (20) were completed until the observed
andcalculatedstructurefactorswereclosetoconvergence,and
there were no large peaks remaining in the Fo–Fc electron
density maps.
A strategy similar to the one detailed for the RT fragment–
DNA structure was used to determine the structure of the RT
fragment–DNA–netropsin complex. Following molecular
replacement phasing, adjustment of the DNA model in the
difference electron density maps in O (19), and completion
of the water structure including 288 water molecules, Fo–Fc
and 2Fo–Fc maps were generated in which nearly continuous
density was observed for the netropsin molecule in the minor
groove of the expected binding site. Netropsin was modeled
into the difference electron density maps using a previously
reﬁnedmodelofnetropsinboundtoDNA(10).Theorientation
of the netropsin molecule was determined based on consid-
eration of the placement of the pyrrole methyl groups and the
carboxamide carbonyl oxygens for which resolved features
were observed in the difference electron density maps. As
in the RT fragment–DNA structure, alternate cycles of
model building using O (19) and reﬁnement using calculations
in CNS (20) were completed until the observed and calculated
structure factors were close to convergence, and there were no
large peaks remaining in the Fo–Fc electron density maps.
There are no ordered water molecules associated with the
DNA in the netropsin complex. A summary of the reﬁnement
statistics is included in Table 1.
In order to conﬁrm the orientation selected for the netropsin
molecule, a reverse orientation for netropsin (with the guan-
idinium and amidinium ends reversed) was ﬁt into the initial
difference maps generated prior toinclusionofnetropsinin the
structural reﬁnement. The reversed netropsin model was then
reﬁned with the same DNA, protein and water model as used
for the original netropsin model. Two large negative peaks
(> 3s) were observed in the Fo–Fc electron density map
corresponding to the position of the N7 pyrrole methyl
group and N6 carboxamide carbonyl for the reversed orienta-
tion of netropsin suggesting that this orientation is not correct.
In contrast, following reﬁnement of the model with the
original orientation of netropsin, no signiﬁcant peaks were
observed in the Fo–Fc maps. Because the complex in this
crystal includes a 30 kDa RT fragment, an 8 bp duplex and
288 water molecules, R values are not particularly sensitive to
the inclusion of netropsin. Small differences in the R-free
values were observed for the correct netropsin model, 24.5%
versus 24.7% for the incorrect model. The R-free value in the
absence of netropsin is 25.2%. As in the other reported struc-
turesofnetropsin–DNAcomplexes,B-factorsforthe netropsin
atoms are higher ( 1.5 times higher) than the B-factors for the
DNA atoms with which they interact. The B-factors associated
with netropsin atoms do not appear to result from less than
full occupancy of netropsin in the structure as reﬁnement of
netropsin at half occupancy results in large positive peaks in
the Fo–Fc maps.
Coordinates for the two structures reported here have been
deposited. The PDB identiﬁers are 1ZTT and 1ZTW corres-
ponding to the RT fragment–DNA complexes with and with-
out netropsin, respectively.
Figures including molecular renderings were genera-
ted using MOLSCRIPT (21) and RASTER 3D (22,23).
Representations of electron density were generated using
CONSCRIPT (21).
RESULTS
Host–guest approach applied to drug–DNA interactions
We have previously reported the use of the N-terminal frag-
ment from MMLV RT, which we refer to here as the RT
fragment, to crystallize and analyze nucleic acid sequences
of interest (2). We now describe the application of this
host–guest system to study the interactions of netropsin
with DNA. The RT-fragment was co-crystallized with a
16mer DNA sequence containing two netropsin binding sites
d(CTTAATTCGAATTAAG)2 in the presence and absence
of netropsin (see Figure 1). Microseeding techniques were
employed to obtain crystals of the desired RT fragment–
DNA complex and RT fragment–DNA–netropsin complex
resulting in diffraction-quality crystals within 1–2 days as
detailed in the Materials and Methods. Unbiased difference
electron density maps obtained from the molecular replace-
ment phasing with the protein alone revealed well-resolved
density for the DNA and signiﬁcant density for the netropsin.
Although it was also possible to soak netropsin into the crys-
tals of the RT fragment complexed with DNA, the resulting
density from the soaking experiment was of poor quality com-
pared to that obtained by co-crystallization. Our analysis of
theRTfragment–DNA–netropsinstructuresuggeststhatdeter-
mination of the structures of other drug–DNA complexes will
be possible using this system.
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Details of the protein structure have been described previously
(24). The asymmetric unit of the Form IV structure contains
one protein molecule and one half of the 16mer as shown
in Figure 1A (2). The oligonucleotide is bound to conserved
residues in the ﬁngers domain of the catalytic fragment of
MMLV-RT as seen in previous structures of the complex
(1–4). There are a total of 8 hydrogen bonds formed between
one protein molecule and the last 3 bp of one end of the 16mer
duplex (Table 2). Of these, two hydrogen bonds are formed by
main chain atoms and the remainder by side chain atoms. The
30-OH of G16 (refer to Figure 1B for numbering scheme) is
hydrogen bonded to the main chain of Leu-115 and Gly-191.
Interactions between side chain atoms of Tyr-64, Asp-114 and
Arg-116 are with minor groove base atoms and sugar atoms
of G16, C1, T2 and T3 as shown in Table 2. The protein–DNA
interactions in the presence and absence of netropsin are
slightly different resulting in a loss of one hydrogen bond
formed in the absence of netropsinand a gain of two additional
hydrogen bonds. For example, Tyr-64 interacts with the
second base of the 50 end (T2 O40) when netropsin is bound
instead of the ﬁrst base (C1 O2) in the absence of netropsin.
Arg-116 also makes an additional contact with the DNA in the
presence of netropsin. In both cases, the oligonucleotide main-
tains a B-form helix that is amenable to netropsin binding.
Details of the DNA structure in the presence and absence of
netropsin are described below.
Netropsin–DNA structure
Two netropsin molecules are bound to the DNA complexed
with MMLV RT in the Form IV structure (Figure 1A), placing
onenetropsinmoleculewithintheasymmetricunit.Asdetailed
in the Materials and Methods, once the DNA and water struc-
tures had been completed, Fo–Fc and 2Fo–Fc maps were gen-
erated in order to model the netropsin molecule bound to the
DNA. As previously suggested, we found that evaluation of
initial difference maps prior to inclusion of netropsin in the
reﬁnement were most useful in determining the orientation of
netropsin (8). Well-resolved electron density for the pyrrole
methyl groups and carboxamide carbonyl oxygen atoms
as shown in Figure 2A allowed us to distinguish the correct
orientation for the netropsin molecule, and the density for the
netropsin molecule improved upon reﬁnement as shown in
Figure 2B and C. No signiﬁcant peaks were observed in the
ﬁnal Fo–Fc maps in the vicinity of the netropsin molecule. As
detailed in the Materials and Methods, ﬁtting of netropsin in
the reverse orientation resulted in two large negative peaks in
the Fo–Fc maps corresponding to the positions of a pyrrole
methyl group and a carboxamide carbonyl group indicating
that this orientation was not correct. Thus, the orientation of
the netropsin is unambiguous in our structure.
Hydrogen bonding between netropsin and the DNA
The single orientation of netropsin identiﬁed in our crystal
lattice and pattern of hydrogen bonds formed between netrop-
sin and the DNA indicate that it is similar to other Class I
netropsin–DNA structures (8). Class I netropsin–DNA struc-
tures exhibit a hydrogen bonding pattern that includes bifurc-
ated hydrogen bonds between the amide NH groups of
netropsin and the A (N3) or T (O2) bases on opposite strands
of the DNA. These hydrogen bonds promote DNA recognition
and binding of the netropsin molecule (12). In our structure,
there are a total of 14 potential hydrogen bonds formed
between netropsin and the DNA of which eight are between
2.7 and 3.2 A ˚ and the remaining six are between 3.3 and 3.4 A ˚
(Table 3, Figure 3).
A comparison of the hydrogen bonds formed between net-
ropsin and DNA in our structure with other class I structures
reveals interesting similarities and differences in the hydrogen
bonding patterns. For the purposes of this analysis, we have
considered potential hydrogen bonds as those for which
donor–acceptor distances are 2.4–3.4 A ˚. Three other structures
including the AATT site have been used for this comparison
includingcomplexesofnetropsinwiththefollowingsequences
d(CGCGAATTCGCG) (8,13), which we will refer to in this
discussion by PDB identiﬁer, 101D, d(CGCAAATTTGCG)
(11), 121D and d(CGCAATTGCG) (12), 261D. The number
of hydrogen bonds between netropsin and the DNA varies
Figure 1. (A) The crystal structure of an RT fragment–DNA–netropsin com-
plex. The asymmetric unit consists of one protein molecule, an 8 bp oligonu-
cleotide duplex and one netropsin molecule representing half of the symmetric
complex. The dashed vertical line divides the symmetrically equivalent halves
ofthe 16bp oligonucleotide.TheDNA oligonucleotideis shownin a redsticks
model,andnetropsinis shownin a purpleCPK model.RTis shownas a ribbon
rendering with b-strands in green, coils in yellow and a-helices in blue except
fortheaDhelixin magenta.ResiduesTyr-64,Asp-114,Leu-115,Arg-116and
Gly-191 that make contacts with the DNA are shown in black ball-and-sticks
models.(B)Schematicoftheoligonucleotideduplexwiththetwocomplemen-
tarystrands(BandG)andthenumberingschemereferredtointhetext.Arrows
denote netropsinmoleculesoriented from guanidinium(tail) to amidinium end
(head).
Table2.HydrogenbondsbetweenRTandDNAinthepresenceandabsenceof
netropsin
Residue Atom Atom Nucleotide Distance (A ˚) Netropsin
Tyr-64 OH O2 C1 3.2 +
O40 T2 3.4  
Asp-114 O
d2 N2 G16 3.0/3.1  /+
Leu-115 N O30 G16 3.0/2.9  /+
Arg-116 N
h2O 4 0 T3 2.8/2.0  /+
O2 T3 3.3 +
N
h2 N2 G16 3.2/3.3  /+
O2 T2 2.7/2.8  /+
O40 T3 3.3/3.3  /+
Gly-191 O O30 G16 2.9/3.0  /+
Nucleic Acids Research, 2005, Vol. 33, No. 13 4109from 7 in 101D to 14 in our structure. All seven hydrogen
bonds found in 101D, which include the bifurcated hydrogen
bonds involving N4, N6 and N8 atoms of netropsin with
O2 and N3 atoms from T and A bases (that are not base-
paired) from complementary strands and an interaction
between N10 and N3 of A, are present in our structure (see
Figure 3B).
The hydrogen bonding pattern observed in the 121D struc-
ture includes eight hydrogen bonds with only one bifurcated
hydrogen bond for the N8 atom of netropsin. Of the possible
hydrogen bond donors present in netropsin, N1, N3, N4, N6,
N8 and N9 are involved in hydrogen bonds with the DNA. As
in our structure, N3 forms a hydrogen bond to an O40 sugar
atom between the ﬁrst two A in the AATT site. The lack of
bifurcated hydrogen bonds for N4 and N6 atoms of netropsin
makes the 121D structure the least similar to the others within
the group of Class I structures.
The 261D structure includes 12 hydrogen bonds between
netropsin and the octamer duplex to which it is bound and also
has bifurcated hydrogen bonding interactions with the N4, N6
and N8 atoms of netropsin. Of the hydrogen bonds observed
in the 261D structure, eight are also found in our structure.
A detailed comparison of the hydrogen bonding interactions
observed in 261D and our structure is shown in Figure 3B
and C. While our structure includes interactions between the
O40 sugar atoms of one strand of the DNA duplex and the N1,
N3, N4, N6 and N8 atoms of netropsin and an N10–O40 hydro-
gen bond to the opposite strand, 261D includes interactions
between O40 sugar atoms and N1 and N10 on only one strand
of the DNA. Our structure also includes hydrogen bonding
interactions with six of the possible NH donors present in
netropsin, while 261D and 121D include interactions with
only ﬁve of the NH donors and 101D, with only four. It is
perhaps of some interest to note that the interactions within the
central region including N4 to N8 of the netropsin molecule
are morehighlyconserved inthedifferentstructuresthanthose
with the N1 and N10 atoms at the ends of the molecule.
Minor groove widths within the netropsin binding site
The netropsin molecule is an asymmetric molecule whose
orientation with respect to the DNA can be deﬁned by the
position of its guanidinium and amidinium ends. Although all
sites in previously reported structures are symmetrical with
respect to sequence in both strands of the DNA (i.e. GAATTC/
gaattc, small letters denote the complementary strand), the
netropsin binding site in our sequence is asymmetrical because
the ﬂanking bases immediately adjacent to the site are differ-
ent (TAATTC/gaatta). Comparison of our structure with other
class I structures suggests that there is no correlation between
the orientation of netropsin bound to the DNA and the nature
of the ﬂanking sequence (i.e. pyrimidine versus purine base).
In addition, the structures of the AATT sites within the Class I
netropsin–DNA structures including those compared above,
101D, 121D and the inverted TTAA site within d(CGCGT-
TAACGCG) (11) (PDB identiﬁer 195D) are very similar with
an average r.m.s.d. of 0.5 A ˚ for superimpositioning of C10
atoms as shown in Figure 4A. The AATT sites of 261D and
our structure are also very similar as shown in Figure 4B in
which the AATT sites are shown along with the netropsin
molecules following superimpositioning of the C10 DNA
atoms within the AATT sites. As was true for the other struc-
turescompared above, the AATT sites withinour structure and
the 261D structure are very similar (r.m.s.d. of 0.3 A ˚). The
netropsin molecules are also very similar. The only signiﬁcant
differences occur in the amidinium ends and result from the
hydrogen bonding to opposite strands of the DNA in the two
structures as shown in Figure 3.
In contrast to previous reports, a detailed analysis of our
DNA structure revealed that while the AATT sequence is
symmetric, the widths of the minor groove are asymmetric
within this site. Unless otherwise stated, 3DNA (25) has been
used to analyze the DNA structures discussed here. Minor
groove widths are calculated in 3DNA based on the cross-
strand distances between phosphate groups (25,26). In our
structure, netropsin is bound such that the guanidinium end
is in the narrow part of the groove at the AATT site while the
amidinium end is in the widest region within the site. Indeed,
analysis of the same netropsin–DNA structures (8,9,11) that
were superimposed on our structure (see Figure 4) revealed
that the increase in minor groove width within the AATT site
Figure 2.(A)Theinitial2Fo–Fcmapofthenetropsindensitycontouredat1sis
showninagreencagerenderingwiththefinalnetropsinmodelsuperimposedin
magenta. (B) The final 2Fo–Fc map of netropsin density contoured at 1s is
shown also in a green cage rendering with the final refined model of netropsin
superimposedinmagenta.(C)Thefinal2Fo–Fcmapisshownsuperimposedon
the final DNA model in blue sticks and the final netropsin model in a magenta
ball-and-stick rendering.
4110 Nucleic Acids Research, 2005, Vol. 33, No. 13is consistent in the other netropsin–DNA structures as shown
in Figure 5A. Further, the orientation of netropsin with respect
to the minor groove width is also consistent, with the guan-
idiniummoiety boundinthe narrowerendof thegroove within
the AATT site. For the inverted site TTAA, the narrowest part
of the groove is the 30 end of the site as is the case for the
AATT sites. The minor groove width increases by 1.5–3 A ˚
within the netropsin binding site from the guanidinium end to
the amidinium end of the netropsin molecule. We have not
included 261D in this comparison as minor groove widths can
be calculated for only 3 bp within this octamer duplex using
3DNA. This correlation of minor groove width with the posi-
tioning of the more rigid guanidinium moiety within the nar-
rower part of the minor groove and amidinium in the wider
part of the minor groove within the AATT site has not been
previously noted.
It has been previously noted that the propeller twist values
are higher within AT sites in DNA structures and that this
featureof the DNA structure contributesto the interactionwith
netropsin (8,13). However, the propeller twist values corres-
ponding to each base pair within the AATT binding site,
deﬁned by the orientation of the netropsin binding, are not
similar in magnitude in the different netropsin–DNA struc-
tures compared in Figure 5B. Therefore, we conclude that
there is no simple correlation between the propeller twist
for each base pair within the AATT site and the orientation
ofthenetropsinbindingwithintheminorgroove.Ourstructure
differs from the reported structures in that the base pair that
interacts with the amidinium end has almost no propeller twist
( .4 );however,thesamebasepairintheabsenceofnetropsin
has a propeller twist at that site of  12.4 . Thus, while pro-
peller twist may provide the narrowed minor groove environ-
ment that draws netropsin to the DNA, it appears to be
the minor groove width that contributes signiﬁcantly to the
directionality of binding.
Comparison of structures with and without
netropsin bound to the DNA
The observed variation in groove width within the AATT site
does not result from the binding of netropsin to the DNA; our
DNA models in the presence and absence of drug possess
nearly identical minor groove widths at the AATT site and
beyond (Figure 6A). However, a comparison of our structu-
res with and without netropsin bound reveal signiﬁcant dif-
ferences consistent with the r.m.s.d. of 0.9 A ˚ obtained for
Figure 3. (A) Diagramof netropsin includingthe numbering scheme for the atoms referred to in the subsequentpanels. (B) The hydrogenbonds between netropsin
and the DNA to which it is bound are shown schematically for this work and (C) the structure reported by Nunn et al. (12), PDB identifier 261D. Arrows denote
netropsinorientedfromguanidinium(N1,tail)toamidiniumend(N10,head).Thenumberingofthebasesin(B)referstotheboldarrowheadrepresentingnetropsin.
The symmetry-related netropsin molecule is represented as a dashed arrow and the vertical dashed line divides the two symmetry related halves of the 16b p
oligonucleotide. Dashed lines between the N atoms of netropsin and the DNA atoms represent hydrogen bonds. Of the 14 hydrogen bonds present in our structure,
8 are also found in the 261D structure.
Table 3. Hydrogen bonds between netropsin and DNA
Netropsin atom DNA atom Chain Distance (A ˚)
N1 N3 of A10 G 2.7
N1 O40 of A11 G 3.2
N3 O40 of A11 G 3.3
N4 O2 of T7 B 2.9
N4 N3 of A11 G 3.0
N4 O40 of T12 G 3.3
N6 O2 of T6 B 3.3
N6 O2 of T12 G 3.2
N6 O40 of T13 G 3.3
N8 N3 of A5 B 3.4
N8 O2 of T13 G 2.8
N8 O40 of A14 G 3.4
N10 N3 of A4 B 2.9
N10 O40 of A4 B 3.2
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structure (Figure 6B). These differences are most signiﬁcant
for the DNA residues that interact with the guanidinium and
amidinium moieties of the netropsin upon comparison with
the structure lacking netropsin. Major changes occur near the
amidinium end where the backbone and base atoms of T3
are pulled in toward the center of the DNA, while those of
A4 are pushed away from the center upon binding of netropsin
(see Figure 1 for numbering scheme). Meanwhile, the struc-
tures of the residues base-paired to T3 and A4, A14 and T13,
Figure 4. (A) Stereodiagram rendering (22,23) of the superimposed AATT netropsin binding sites of this work and several known netropsin–DNA structures.
C10 atoms from all 4 bp comprising the AATT sites were superimposed in O (19) based on directionality of netropsin binding. Reported structures are labeledb y
their PDB identifier. This work (AATT) in blue; 101D (AATT) in red, r.m.s.d ¼ 0.4 A ˚; 121D (AATT) in orange, r.m.s.d. ¼ 0.4 A ˚; 195D (TTAA’) in green,
r.m.s.d. ¼ 0.6A ˚.(B)ThestructuresoftheAATTsiteinourstructure(blue)andthatinthe261Dstructure(yellow)weresuperimposedasaboveusingC10 atomswith
an r.m.s.d. ¼ 0.3 A ˚. The netropsin molecules are shown for our structure (green) as well as the 261D structure (red).
Figure 5. (A) Minor groove widths (in A ˚), calculated in 3DNA based on cross-strand distances of phosphate groups (25,26) and (B) propeller twist (in degrees) of
base-pairstepsinnetropsinbindingsitesinthepresenceofnetropsinaregraphedaccordingtobindingdirectionalityofnetropsintotheDNA.Reportedstructuresare
labeled as their Protein Data Bank ID. This work (black diamond), 101D (open square) and 121D (X) are AATT sites; 195D (D) is a TTAA site.
4112 Nucleic Acids Research, 2005, Vol. 33, No. 13respectively, are similar to that of the DNA in the absence of
netropsin. Near the guanidinium end of netropsin, the back-
bone and base atoms of A10 and A11 are shifted relative to
their positions in the structure without netropsin. The differ-
ences observed for T3 and A4 on one strand and A10 and A11
of the complementary strand appear to be a direct result of
netropsin binding as they coincide with the pattern of hydro-
gen bonding between DNA and the drug as shown in
Figure 3B; hydrogen bonds with the backbone may affect
the positions of the sugar rings so that the DNA can accom-
modate netropsin. In addition to the changes observed in the
positions of the DNA atoms upon binding of netropsin, a
number of other structural changes in the DNA occur near
the ends of the netropsin binding site: increased base-pair
opening at the T7–A10 step ( 7.8  versus 5.2 ), increased
roll (4.8  versus 13.2 ) and inclination (7.7  versus 24.3 )
of T3–A14/A4–T13, and decreased tip (7.1  versus  1.9 )
of T3–A14/A4–T13 for the structures in the absence and pres-
ence of netropsin, respectively. Although netropsin binding to
DNA causes alterations in structure for DNA residues sur-
rounding the netropsin binding site, the minor groove widths
of the DNA remain the same whether the netropsin is bound
or not. Furthermore, we analyzed the previously reported
DNA structure d(CGCGAATTCGCG) in the presence (PDB
accession ID 6BNA) and absence (3BNA) of netropsin, and
found that minor groove widths were the same even though a
number of structural changes were evident upon netropsin
binding (data not shown) (13,27). Thus, we conclude that the
differences in minor groove widths within the AATT site are
structural features of the DNA that promote directionality of
netropsin binding within the site.
Comparison of the netropsin structures
To compare the curvature of the netropsin molecules bound in
the various netropsin–DNA structures, the netropsin models
were superimposed onto our model of netropsin using those
atoms in the guanidinium end through the ﬁrst pyrrole ring
(Figure 7) (8,9,11–13). This region of the netropsin molecule
is quite similar (average r.m.s.d. ¼ 0.3 A ˚), whereas the
orientation of the amidinium ends of the netropsin molecule
differ such that the superimposed molecules form a fan shape.
The degree of curvature for the netropsin models observed
appears to correlate with the interactions of the ends of the
netropsin molecule with the DNA. For the most curved net-
ropsin modelsincluding our structure,the 261D (12) and 195D
(9) models, both N1 and N10 atoms of netropsin form hydro-
gen bonds with the DNA. In the least curved models including
101D and 121D, interactions with the DNA include either N1
or N10 netropsin atoms but not both. The different conforma-
tions of netropsin and the alterations in DNA structure when
netropsin is bound suggest that there is a compromise between
Figure 6. (A) Minor groove widths of DNA base-pair steps (from 3DNA calculations) in the absence (open circle) and presence (black diamond) of netropsin.
(B) Stereo diagram of structures of DNA in the absence (red) and presence (blue) of netropsin (r.m.s.d ¼ 0.9 A ˚). Superimpositioning of C10 of all 16 bp was done
using O (19).
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and structural changes that stabilize netropsin–DNA inter-
actions, potentially an induced ﬁt, akin to that reported for
an analogue of Hoechst 33258 binding to A-tract DNA (28).
Thus, netropsin binds with the more rigid guanidinium moiety
near the narrow part of the groove allowing the more adjust-
able amidinium end to be accommodated in the wider part of
the groove within the AATT binding site.
In conclusion, netropsin in our structure is a Class I binder
with a clearly distinguished orientation. Analysis of the minor
groove widths in the netropsin binding site reveals for the ﬁrst
time that the guanidinium end is located in the narrow part of
the groove, while the amidinium end binds at the wider part
of the groove. Further analyses of previously reported Class I
netropsin–DNA complexes support and conﬁrm this observa-
tion. We propose that the asymmetrical groove widths in this
otherwise sequence-symmetrical site contribute to the orienta-
tion of the netropsin molecule within the minor groove.
DISCUSSION
Structures of netropsin–DNA interactions have been reported
for >20 years and have led to theories about the directionality
of netropsin binding. However, a comparative analysis of
all the available Class I netropsin–DNA structures suggests
that the factors previously suggested as contributing to the
orientation of netropsin binding are not correlated in all of
the structures. The structures and comparative analysis presen-
ted here provide new insights on the directionality of netropsin
binding.
It has been proposed that the speciﬁcity of netropsin binding
results in part from the high propeller twist of AT sites leading
to a narrow minor groove, in comparison with the surround-
ing GC sites (27). Analysis of our netropsin-boundDNA struc-
ture and several previously reported structures has revealed
that the propeller twist values within the AATT sites are not
correlated with the orientation of netropsin binding
(Figure 5B). Thus, although the netropsin molecule may
recognize the DNA based on the overall narrowed groove
environment created by the high propeller twist of AT sites,
this factor does not provide a basis for understanding the
direction of netropsin binding.
Another possible factor in directional binding is the con-
tribution of the sequence ﬂanking the AATT site. In contrast to
previously reported structures, our structure is the ﬁrst
netropsin–DNA structure in which two netropsin molecules
are bound to one DNA molecule in two distinct AATT sites
(Figure 1) rather than end-to-end in IC-containing decamers
and bridged by one water molecule (29). The TAATTC site
within our DNA is a non-symmetric site within a symmetric
oligonucleotide, whereas the sites within the reported
netropsin–DNA structures are completely symmetrical [i.e.
GAATTC (13)]. Thus, symmetry surrounding the site is not
required for netropsin binding. Furthermore, the bases imme-
diately adjacent to the AT sites in the known structures vary
but do not appear to have an effect on orientation of the
netropsin molecule within the site.
The ﬁrst crystal structure of netropsin bound to DNA
revealed that molecular speciﬁcity of the drug for AT sites
resulted from hydrogen bonds formed between the drug and
DNA (7,13). Assessment of the hydrogen bonding pattern of
netropsin bound to AATT or TTAA in subsequent work sug-
gested that the netropsin molecule is oriented based on the
presence or absence of hydrogen bonds between the amide N6
and the DNA (9). The amide N6 of netropsin displays bifurc-
ated hydrogen bonding to each strand of the AATT site in our
structure, the original structure, d(CGCGAATTCGCG) (13)
and the d(CGCAATTGCG) (12), but forms a single hydrogen
bond to one strand of the DNA in the AATT site within the
sequenced(CGCAAATTTGCG) (11)andthe TTAA sequence
d(CGCGTTAACGCG) (9,11). Further analysis of hydrogen
bonding patterns reveals that both the number of hydrogen
bonds as well as the speciﬁc hydrogen bonds formed varies in
the different structures that have been analyzed. Thus, hydro-
gen bonding patterns may affect the afﬁnity of netropsin for
the DNA, as netropsin selectively binds AATT over TTAA
sites (6),butarenotcorrelatedwith theorientation ofnetropsin
binding within the AATT site.
The factor that we have identiﬁed in all of the structures
analyzed that contributes to the orientation of netropsin bind-
ing is the minor groove width within the AATT site. Specif-
ically, the planar guanidinium end is bound in the narrow
region of the AATT site whereas the more ﬂexible amidinium
end is situated in the wider part of the site. Thus, the narrow
minor groove width within AT-rich sites probably contributes
to the sequenceselectivity of netropsin and other minorgroove
binding drugs (30,31), while variations of the minor groove
width within the AATT site contribute to the orientation of
netropsin binding.
Our ﬁnding regarding differences in minor groove width
within a site leading to an orientational preference for netrop-
sin is similar to that reported for the Hoechst 33258 (H33258)
bound to an A-tract sequence in a 2:1 H33258:DNA complex.
In that complex, H33258 was found to bind with a preferred
orientation dictated by the ﬁt of the benzimidazole portion of
the compound in the narrowest part of the minor groove and
Figure 7. Superimposed netropsin molecules from our structure and several
known netropsin–DNA structures. Structures of the atoms from the guanidi-
nium end through the first pyrrole ring were superimposed using LSQKAB
in CCP4i (33,34). Reported structures are labeled by their Protein Data
Bank ID. This work in blue; 101D in red, r.m.s.d ¼ 0.4 A ˚; 121D in orange,
r.m.s.d. ¼ 0.5 A ˚; 195D in green, r.m.s.d. ¼ 0.2 A ˚; 261D in magenta,
r.m.s.d ¼ 0.3 A ˚.
4114 Nucleic Acids Research, 2005, Vol. 33, No. 13the N-methylpiperazine ring binding in the wider part of the
groove (30).
In this study of netropsin–DNA interactions, we have val-
idated our host–guest approach to the study of DNA–drug
interactions and provided new information about the direc-
tional DNA binding of netropsin. Signiﬁcant advantages of
this host–guest system include the ability to use any DNA
sequence and to obtain unbiased density for the DNA and
the ligand by molecular replacement phasing using a previ-
ously reﬁned model of the RT fragment. In addition, we envi-
sion that the lack of DNA–DNA interactions within the lattice
may allow us to study DNA binding molecules that have
previously proven refractory to crystallographic analysis. A
limitation of the system is the length of oligonucleotide that
can be crystallized. Furthermore, as is true in all crystallo-
graphic studies of drug–DNA complexes, determination of the
interactions of the drug with the DNA in this system requires
site-speciﬁc drugs. Netropsin is not only site-speciﬁc, but is
also a very tight binder with a Kd of 4 · 10
 9 M for 1:1
binding for AT-rich DNA sites (32). Our initial success with
netropsin suggests that the system will be amenable to the
study of new DNA binding compounds.
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